apollo
0

Welcome User

Login/Sign Up

Home
Buy Medicines
Lab Tests
Doctor Consult
Circle Membership
insurance
Blogs
Contact Us
Privacy Policy
Return & Refunds
Need Help
Terms and Conditions
  1. Home
  2. Medicine

  3. Lucentis 10 mg Injection 0.23 ml

Lucentis 10 mg Injection 0.23 ml, Pack of 1 INJECTION
Offers on medicine orders
All offers
axis icici
Written By Santoshini Reddy G , M Pharmacy
Reviewed By Dr Aneela Siddabathuni , MPharma., PhD

Lucentis 10 mg Injection 0.23 ml is used to treat eye diseases causing vision impairment, such as neovascular (wet) age-related macular degeneration, macular oedema following retinal vein occlusion, diabetic macular oedema, proliferative diabetic retinopathy, and choroidal neovascularization. It is also used to treat retinopathy of prematurity in babies born prematurely. Lucentis 10 mg Injection 0.23 ml contains Ranibizumab, a vascular endothelial growth factor A (VEGF-A) antagonist, which binds to VEGF-A (a protein which causes abnormal blood vessel growth and swelling, leading to vision impairment) present in the eyes, blocks its action and prevents abnormal growth and swelling. Thus, it helps stabilize and improve your vision.

Read more
rxMedicinePrescription drug

Whats That

tooltip

Also Explore

Momverse
Ask Apollo
insurance

Composition :

RANIBIZUMAB-10MG

Manufacturer/Marketer :

Novartis India Ltd

Consume Type :

PARENTERAL

Return Policy :

Not Returnable

Expires on or after :

About Lucentis 10 mg Injection 0.23 ml

Lucentis 10 mg Injection 0.23 ml belongs to the group of medicines called anti-neovascularisation agents used to treat eye diseases causing vision impairment, such as neovascular (wet) age-related macular degeneration, macular oedema following retinal vein occlusion, diabetic macular oedema, proliferative diabetic retinopathy, and choroidal neovascularization. It is also used to treat retinopathy of prematurity in babies born prematurely.

Lucentis 10 mg Injection 0.23 ml contains Ranibizumab, a vascular endothelial growth factor A (VEGF-A) antagonist. It binds to VEGF-A (a protein that causes abnormal blood vessel growth and swelling, leading to vision impairment) present in the eyes, blocks its action, and prevents abnormal growth and swelling. It helps stabilise and improve vision.

In some cases, Lucentis 10 mg Injection 0.23 ml may cause side effects such as eye pain, inflammation, retinal bleeding, dry eye, eye irritation, and redness or itching of the eye. Most of these side effects may not require medical attention and resolve over time. However, you are advised to talk to the doctor if any of the side effects persist or worsen.

Let the doctor know if you are allergic to any components in Lucentis 10 mg Injection 0.23 ml. Consult the doctor if you are pregnant, think you may be pregnant or planning for pregnancy. Lucentis 10 mg Injection 0.23 ml is not recommended during breastfeeding. Keep your doctor informed about your health condition and medications to rule out any side effects/interactions.

Uses of Lucentis 10 mg Injection 0.23 ml

Lucentis 10 mg Injection 0.23 ml is used in the treatment of Neovascular (wet) age-related macular degeneration (AMD), macular oedema following retinal vein occlusion (RVO), diabetic macular oedema (DME), proliferative diabetic retinopathy (PDR), and choroidal neovascularization (CNV). Also used in premature babies to treat retinopathy of prematurity (ROP). The detailed uses of Lucentis 10 mg Injection 0.23 ml are as follows:<br/>• Treat wet age-related macular degeneration (AMD): Lucentis 10 mg Injection 0.23 ml inhibits abnormal blood vessel growth under the retina, helping preserve central vision and slow disease progression.<br/>• Manage diabetic macular edema (DME): Lucentis 10 mg Injection 0.23 ml reduces retinal swelling caused by fluid leakage in diabetic patients, improving visual acuity.<br/>• Treat macular edema due to retinal vein occlusion (RVO): Lucentis 10 mg Injection 0.23 ml helps restore vision by reducing fluid buildup in the retina following vein blockage.<br/>• Support therapy for diabetic retinopathy: Lucentis 10 mg Injection 0.23 ml improves retinal health and prevents further damage in patients with advanced diabetic eye disease.<br/>• Treat myopic choroidal neovascularization (mCNV): Lucentis 10 mg Injection 0.23 ml is used to manage vision loss in patients with severe nearsightedness due to abnormal blood vessel growth.<br/>

Directions for Use

• Follow your doctor's instructions on the dosage and timing of this medication, to improve effectiveness.• Lucentis 10 mg Injection 0.23 ml will be administered by a healthcare professional.• Do not self-administer it.

Medicinal Benefits

Lucentis 10 mg Injection 0.23 ml belongs to the group of medicines called anti-neovascularisation agents used to treat eye diseases causing vision impairment, such as neovascular (wet) age-related macular degeneration (AMD), macular oedema following retinal vein occlusion (RVO), diabetic macular oedema (DME), proliferative diabetic retinopathy (PDR), and choroidal neovascularization (CNV). Lucentis 10 mg Injection 0.23 ml contains Ranibizumab, a vascular endothelial growth factor A (VEGF-A) antagonist, which binds to VEGF-A (a protein which causes abnormal blood vessel growth and swelling, leading to vision impairment) present in the eyes, blocks its action and prevents abnormal growth and swelling. It helps stabilise and improve your vision. This medicine may also be indicated in preterm infants for the treatment of retinopathy of prematurity (ROP).

How Lucentis 10 mg Injection 0.23 ml Works

Lucentis 10 mg Injection 0.23 ml contains Ranibizumab, a vascular endothelial growth factor A (VEGF-A) antagonist. It binds to VEGF-A (a protein that causes abnormal blood vessel growth and swelling, leading to vision impairment) present in the eyes, blocks its action, and prevents abnormal growth and swelling. It helps stabilise and improve vision.

Storage

• Store in a cool and dry place away from sunlight.• Keep Lucentis 10 mg Injection 0.23 ml out of reach and sight of children.• Cold chain - To be stored in cold places at 2ºC to 8ºC.

What if I have taken an overdose of Lucentis 10 mg Injection 0.23 ml

As Lucentis 10 mg Injection 0.23 ml is a parenteral formulation administered by experienced medical staff, the chance of overdose may be less. However, if you think there has been an overdose or experiencing any adverse events, get medical care right away.

Drug Warnings

Do not receive Lucentis 10 mg Injection 0.23 ml if you are allergic to any of its components, if you have an infection in or around the eye, severe intraocular inflammation (pain or redness in the eye) or if you are breastfeeding. Consult the doctor if you are pregnant, think you may be pregnant or planning for pregnancy. Seek immediate medical attention if you experience worsening eye redness, eye pain or increased discomfort, an increased number of small particles in your vision, blurred or decreased vision, or increased sensitivity to light. Inform the doctor if you have a history of eye conditions, eye treatments, or stroke. Let the doctor know if you are taking any other medicines, including supplements or herbal products.

Diet & Lifestyle Advise

  • Eat a healthy diet and exercise regularly to maintain proper weight.
  • Avoid smoking and alcohol consumption.
  • Include vegetables, whole grains, and fruits in your diet.
  • Get optimal sleep; rest well.

Habit Forming

No

Therapeutic Class

OPHTHALMOLOGIC AGENTS

Lucentis 10 mg Injection 0.23 ml Substitute

Substitutes safety advice

Product Substitutes

bannner image

Alcohol

Consult your doctor

It is not known if alcohol interacts with Lucentis 10 mg Injection 0.23 ml. Please consult the doctor.

bannner image

Pregnancy

Caution

Lucentis 10 mg Injection 0.23 ml should not be used during pregnancy unless the benefits outweigh the risks. Consult the doctor if you are pregnant, think you may be pregnant or planning for pregnancy.

bannner image

Breast Feeding

Unsafe

It is not known whether Lucentis 10 mg Injection 0.23 ml passes into breast milk. However, if you are breastfeeding, inform your doctor before receiving Lucentis 10 mg Injection 0.23 ml.

bannner image

Driving

Caution

Lucentis 10 mg Injection 0.23 ml may cause temporary vision blurring. Avoid driving or operating heavy machinery if you experience this.

bannner image

Liver

Caution

If you have a history of liver problems, inform the doctor before receiving Lucentis 10 mg Injection 0.23 ml.

bannner image

Kidney

Caution

Dose adjustment may not be needed in patients with renal impairment. However, if you have a history of kidney problems, inform the doctor before receiving Lucentis 10 mg Injection 0.23 ml.

bannner image

Children

Caution

Lucentis 10 mg Injection 0.23 ml is not recommended for children as the safety and effectiveness have not been established except for retinopathy of prematurity (ROP) in babies born prematurely. However, the safety profile in preterm infants has not been established beyond 2 years.

Have a query?

FAQs

Lucentis 10 mg Injection 0.23 ml is used to treat Neovascular (wet) age-related macular degeneration (AMD), macular oedema following retinal vein occlusion (RVO), diabetic macular oedema (DME), proliferative diabetic retinopathy (PDR), and choroidal neovascularization (CNV). Also used in premature babies to treat retinopathy of prematurity (ROP).

Lucentis 10 mg Injection 0.23 ml works by stopping abnormal blood vessel growth and leakage in the eyes that may cause vision loss.

Lucentis 10 mg Injection 0.23 ml may affect fertility. Fertility problems may interfere with the ability to get pregnant or father a child. Consult the doctor if you have any concerns.

Lucentis 10 mg Injection 0.23 ml can be used in the elderly aged 65 years or older if prescribed by the doctor. However, talk to the doctor if you have any concerns.

Lucentis 10 mg Injection 0.23 ml should not be used by individuals who are allergic to any of its active ingredients and those who have an eye infection, eye inflammation, or severe inflammation within the eye. Always consult your healthcare provider before using this medication.

The duration of treatment with Lucentis 10 mg Injection 0.23 ml depends on the condition being treated and your response to the medication. Your healthcare provider will determine the appropriate length of treatment.

After taking Lucentis 10 mg Injection 0.23 ml, inform your doctor if you experience eye pain, discomfort, redness, blurred vision, or increased sensitivity to light. Monitor for signs of infection or retinal detachment, and contact your doctor if these occur. Your doctor may also check eye pressure, as it can temporarily rise. Additionally, inform your doctor if you have a history of eye conditions or stroke-related symptoms.

Lucentis 10 mg Injection 0.23 ml causes side effects such as inflammation of eye, retinal bleeding (bleeding in the back of eye), eye pain, a bloodshot eye, small particles or spots in the vision, eye irritation, dry eye, redness or itching in eye, and increased eye pressure. However, please contact a doctor if these side effects persist for longer durations.

Country of origin

India

Manufacturer/Marketer address

Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India
Other Info - LUC0038

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
icon image

Keep Refrigerated. Do not freeze.Prepaid payment required.

Author Details

Santoshini Reddy GDoctor badge

Written By

Santoshini Reddy G

M Pharmacy

Dr Aneela SiddabathuniDoctor badge

Reviewed By

Dr Aneela Siddabathuni

MPharma., PhD

Last Updated

Jul 18, 2025 | 7:06 AM IST

Doctor imageWe provide you with authentic, trustworthy and relevant information

Reference

  1. https://www.medicines.org.uk/emc/files/pil.307.pdf
  2. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125156s105lbl.pdf
  3. https://www.novartis.com/sg-en/sites/novartis_sg/files/Lucentis-Feb2022.SIN-app180522-pdf.pdf
  4. https://medlineplus.gov/druginfo/meds/a607044.html
  5. https://www.drugs.com/cdi/ranibizumab.html

Buy best Ocular products by

whatsapp Floating Button